Joseph Donahue, most recently head of global sales and president of Lion Bioscience’s US subsidiary, has left the company, BioInform has learned. A company spokeswoman said that a replacement has not yet been named. Donahue joined Lion in 2003 as president of its North American operations. In October 2004, he was appointed co-CEO of the company, along with Thure Etzold. In November, Lion’s supervisory board removed Donahue from the executive board and appointed Etzold CEO and Peter Willinger CFO.